Bröker LE - Search Results

1

Late activation of apoptotic pathways plays a negligible role in mediating the cytotoxic effects of discodermolide and epothilone B in non-small cell lung cancer cells.

Bröker LE, Huisman C, Ferreira CG, Rodriguez JA, Kruyt FA, Giaccone G. Bröker LE, et al. Cancer Res. 2002 Jul 15;62(14):4081-8. Cancer Res. 2002. PMID: 12124345

2

Paclitaxel triggers cell death primarily via caspase-independent routes in the non-small cell lung cancer cell line NCI-H460.

Huisman C, Ferreira CG, Bröker LE, Rodriguez JA, Smit EF, Postmus PE, Kruyt FA, Giaccone G. Huisman C, et al. Among authors: broker le. Clin Cancer Res. 2002 Feb;8(2):596-606. Clin Cancer Res. 2002. PMID: 11839682

3

The role of new agents in the treatment of non-small cell lung cancer.

Bröker LE, Giaccone G. Bröker LE, et al. Eur J Cancer. 2002 Dec;38(18):2347-61. doi: 10.1016/s0959-8049(02)00457-4. Eur J Cancer. 2002. PMID: 12460778 Review.

4

Cathepsin B mediates caspase-independent cell death induced by microtubule stabilizing agents in non-small cell lung cancer cells.

Bröker LE, Huisman C, Span SW, Rodriguez JA, Kruyt FA, Giaccone G. Bröker LE, et al. Cancer Res. 2004 Jan 1;64(1):27-30. doi: 10.1158/0008-5472.can-03-3060. Cancer Res. 2004. PMID: 14729603

5

Cell death independent of caspases: a review.

Bröker LE, Kruyt FA, Giaccone G. Bröker LE, et al. Clin Cancer Res. 2005 May 1;11(9):3155-62. doi: 10.1158/1078-0432.CCR-04-2223. Clin Cancer Res. 2005. PMID: 15867207 Review.

6

Phase I trial with BMS-275183, a novel oral taxane with promising antitumor activity.

Bröker LE, de Vos FY, van Groeningen CJ, Kuenen BC, Gall HE, Woo MH, Voi M, Gietema JA, de Vries EG, Giaccone G. Bröker LE, et al. Clin Cancer Res. 2006 Mar 15;12(6):1760-7. doi: 10.1158/1078-0432.CCR-05-2093. Clin Cancer Res. 2006. PMID: 16551860 Free article. Clinical Trial.

7

A phase I safety and pharmacologic study of a twice weekly dosing regimen of the oral taxane BMS-275183.

Bröker LE, Veltkamp SA, Heath EI, Kuenen BC, Gall H, Astier L, Parker S, Kayitalire L, Lorusso PM, Schellens JH, Giaccone G. Bröker LE, et al. Clin Cancer Res. 2007 Jul 1;13(13):3906-12. doi: 10.1158/1078-0432.CCR-06-2875. Clin Cancer Res. 2007. PMID: 17606724 Clinical Trial.

8

Effect of food on the pharmacokinetic behavior of the potent oral taxane BMS-275183.

Bröker LE, Valdivieso M, Pilat MJ, Deluca P, Zhou X, Parker S, Giaccone G, Lorusso PM. Bröker LE, et al. Clin Cancer Res. 2008 Jul 1;14(13):4186-91. doi: 10.1158/1078-0432.CCR-07-4594. Clin Cancer Res. 2008. PMID: 18593998 Free article. Clinical Trial.

9

Upper gastrointestinal symptoms, psychosocial co-morbidity and health care seeking in general practice: population based case control study.

Bröker LE, Hurenkamp GJ, ter Riet G, Schellevis FG, Grundmeijer HG, van Weert HC. Bröker LE, et al. BMC Fam Pract. 2009 Sep 9;10:63. doi: 10.1186/1471-2296-10-63. BMC Fam Pract. 2009. PMID: 19740413 Free PMC article.

10

[Juvenile xanthogranuloma: a form of histiocytosis with an excellent prognosis].

Bröker LE, van den Berg H, van Groningen K, van der Wateren AR, de Nef JJ. Bröker LE, et al. Ned Tijdschr Geneeskd. 2001 Mar 31;145(13):635-9. Ned Tijdschr Geneeskd. 2001. PMID: 11305214 Dutch.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters